tiprankstipranks
Trending News
More News >
Albert David Ltd (IN:ALBERTDAVD)
:ALBERTDAVD
India Market
Advertisement

Albert David Ltd (ALBERTDAVD) AI Stock Analysis

Compare
0 Followers

Top Page

IN:ALBERTDAVD

Albert David Ltd

(ALBERTDAVD)

Rating:65Neutral
Price Target:
₹964.00
▲(19.95% Upside)
Albert David Ltd's stock score reflects a stable balance sheet with low debt but is hampered by declining revenue and profitability, along with negative cash flow trends. Technical indicators are mixed, and the stock appears overvalued with a high P/E ratio and low dividend yield. These factors contribute to a cautious outlook.

Albert David Ltd (ALBERTDAVD) vs. iShares MSCI India ETF (INDA)

Albert David Ltd Business Overview & Revenue Model

Company DescriptionAlbert David Ltd. is a pharmaceutical and healthcare company based in India. It operates in the pharmaceutical sector, focusing on manufacturing and marketing a wide range of healthcare products, including bulk drugs, formulations, intravenous fluids, and herbal products. The company is committed to delivering quality healthcare solutions both domestically and internationally.
How the Company Makes MoneyAlbert David Ltd. generates revenue primarily through the sale of its pharmaceutical products, which include a variety of formulations and bulk drugs. The company's revenue streams include domestic sales within India and exports to international markets. Key products contributing to its revenue include intravenous fluids, therapeutic formulations, and herbal products. Additionally, the company may engage in strategic partnerships and collaborations to enhance its distribution network and market reach, further contributing to its earnings.

Albert David Ltd Financial Statement Overview

Summary
Albert David Ltd demonstrates strength in its balance sheet with low leverage and strong equity. However, declining revenue and profitability, along with negative operating and free cash flows, are critical challenges. The company must address these issues to sustain long-term growth and financial health.
Income Statement
65
Positive
Albert David Ltd has shown a mixed performance in terms of revenue and profitability. The gross profit margin is strong, indicating effective cost management, but the net profit margin has declined significantly in the latest year, reflecting a decrease in profitability. Revenue has shown fluctuations, with a notable decline in the most recent year, which is a concern for growth prospects.
Balance Sheet
78
Positive
The company's balance sheet reflects solid equity and a low level of debt, which is a positive indicator of financial stability. The equity ratio is robust, and the company has maintained a strong return on equity, although it has decreased in the latest year. The low debt-to-equity ratio limits financial risk.
Cash Flow
55
Neutral
Cash flow from operations has turned negative in the latest year, which is a significant drawback. Free cash flow also fell into negative territory, indicating potential liquidity issues. In previous years, cash flow metrics were healthier, but the recent downturn in free cash flow growth rate raises concerns about the company's ability to generate cash.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.46B3.46B3.60B3.42B3.12B2.46B
Gross Profit2.29B2.29B2.32B2.18B1.95B1.58B
EBITDA30.26M30.26M1.05B598.68M567.76M364.59M
Net Income172.01M172.01M754.20M361.75M352.58M221.43M
Balance Sheet
Total Assets5.11B5.11B4.98B4.23B4.03B3.41B
Cash, Cash Equivalents and Short-Term Investments2.44B2.44B2.85B2.08B1.75B1.49B
Total Debt123.17M123.17M33.24M53.18M56.62M16.19M
Total Liabilities1.19B1.19B1.15B1.12B1.23B970.20M
Stockholders Equity3.92B3.92B3.83B3.12B2.79B2.44B
Cash Flow
Free Cash Flow0.00-432.92M346.28M52.78M292.83M349.79M
Operating Cash Flow0.00-284.36M455.02M105.15M403.65M366.11M
Investing Cash Flow0.00233.01M-391.08M-49.95M-396.97M-366.84M
Financing Cash Flow0.001.10M-82.70M-63.62M-48.80M-17.05M

Albert David Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price803.65
Price Trends
50DMA
858.09
Negative
100DMA
843.50
Negative
200DMA
979.88
Negative
Market Momentum
MACD
-14.76
Negative
RSI
38.72
Neutral
STOCH
43.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ALBERTDAVD, the sentiment is Negative. The current price of 803.65 is below the 20-day moving average (MA) of 807.80, below the 50-day MA of 858.09, and below the 200-day MA of 979.88, indicating a bearish trend. The MACD of -14.76 indicates Negative momentum. The RSI at 38.72 is Neutral, neither overbought nor oversold. The STOCH value of 43.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ALBERTDAVD.

Albert David Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
₹4.58B72.68
0.62%-9.14%-91.11%
58
Neutral
₹3.57B47.55
19.40%1286.88%
54
Neutral
₹3.65B38.50
-3.36%-47.58%
51
Neutral
$7.92B-0.43-41.67%2.21%22.29%-1.85%
47
Neutral
₹4.22B
9.42%-13120.00%
45
Neutral
₹4.26B347.96
10.30%
43
Neutral
₹3.29B30.02
-3.41%-3028.44%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:ALBERTDAVD
Albert David Ltd
803.65
-732.69
-47.69%
IN:BROOKS
Brooks Laboratories Limited
151.85
17.35
12.90%
IN:LYKALABS
Lyka Labs Limited
99.22
-56.78
-36.40%
IN:NECLIFE
Nectar Lifesciences Ltd.
14.66
-37.03
-71.64%
IN:VIKASLIFE
Vikas Lifecare Limited
2.26
-2.55
-53.01%
IN:ZIMLAB
Zim Laboratories Ltd.
74.20
-45.50
-38.01%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 31, 2025